Doğan, Umuttan2020-03-262020-03-262010Doğan, U., (2010). Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?. Anadolu Kardiyoloji Dergisi, (10), 41-42. Doi: 10.5152/akd.2010.0091302-87231308-0032http://www.trdizin.gov.tr/publication/paper/detail/TVRBd05EazRPQT09https://hdl.handle.net/20.500.12395/24235The prevalence of atrial fibrillation (AF) is high and it is expected to increase in the near future (1). AF is a strong independent risk factor for ischemic stroke and systemic arterial embolisation (2). Oral anticoagulation (OAC) has been shown to decrease the risk of stroke. In a meta-analysis of 6 randomized trials including 2900 participants, the estimated relative risk reduction is reported as 64% (3). Despite the evident benefits, OAC is underused even in high risk AF patients (4, 5).[Abstract not Available]eninfo:eu-repo/semantics/openAccessKalp ve Kalp Damar SistemiOther10414220150003WOS:000275102800009N/A